Home
About
Contact
About Me
Heal Research
Home
Features
_Multi DropDown
__DropDown 1
__DropDown 2
__DropDown 3
_ShortCodes
_SiteMap
_Error Page
Mega Menu
Documentation
_Web Documentation
_Video Documentation
Home
News Medical Medical Research News Feed
No benefit of low dose apixaban following acute COVID-19
No benefit of low dose apixaban following acute COVID-19
Preetam Gupta
18:17
The HEAL-COVID trial compared the efficacy of Apixaban to standard care in adults who have recently recovered from severe COVID-19.
from News Medical Medical Research News Feed https://ift.tt/DvyZSYT
Post a Comment
0 Comments
Social Plugin
Popular Posts
Municipalities with low socioeconomic status in Greater Santiago have higher COVID-19 mortality
22:05
Scientists estimate 2 to 3 percent of Hubei Province’s population has been infected with coronavirus
23:14
US secures almost entire world stock of Covid-19 drug Remdesivir
22:42
Technology
3/Technology/post-list
Categories
Tags
0 Comments